StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Stifel Positive on Vertex (VRTX) as Triple Combo Moves Forward; PT Trimmed to $108
October 26, 2016 9:22 AM
Stifel analyst Adam Walsh trimmed his price target on Vertex (NASDAQ: VRTX) to $108.00 (from $109.00) but maintained a Buy ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Jefferies Reiterates Buy on Vertex Pharma (VRTX) Following Investor Event
October 28, 2016 7:54 AM
Vertex Pharma (VRTX): Cutting PT But Fundamentals Continue To Look Good - Jefferies
October 26, 2016 8:39 AM
Vertex Pharma (VRTX): Many Shots on Goal But Uncertain Safety Limits Upside - Leerink
October 26, 2016 7:02 AM
Vertex (VRTX) PT Bumped to $88 at BMO Capital Following Results and Triple Combo Update
October 26, 2016 6:51 AM
Vertex Pharma (VRTX) Misses Q3 EPS by 2c; Plans to Commence Two CF-Focused Phase 2s
October 25, 2016 4:04 PM
Vertex Reports Third Quarter 2016 Financial Results
October 25, 2016 4:03 PM
